Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cochlear ( (AU:COH) ) has issued an announcement.
Cochlear Limited announced its preliminary final report for the fiscal year ending June 30, 2025, showing a 4% increase in sales revenue to A$2,355.8 million and a 9% rise in net profit attributable to shareholders to A$388.9 million. The company’s earnings before interest and taxes (EBIT) also grew by 9%, reflecting strong operational performance. The dividend per share increased by 5% to A$4.30, indicating a positive outlook for shareholders. These results underscore Cochlear’s robust financial health and its solid positioning in the medical device industry, with implications for continued growth and shareholder value.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$311.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company focuses on providing innovative hearing implants that improve the quality of life for individuals with hearing loss.
Average Trading Volume: 173,116
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.4B
Learn more about COH stock on TipRanks’ Stock Analysis page.